Associations between candidate loci angiotensin-converting enzyme and angiotensinogen with coronary heart disease and myocardial infarction: The NHLBI Family Heart Study

Annals of Epidemiology

Volumn 7, Issue 1, 1997, Pages 3-12

  Ludwig, E H ^a   Borecki, I B ^b   Ellison, R C ^c   Folsom, A R ^d   Heiss, G ^e   Higgins, M ^f   Lalouel, J M ^a   Province, M A ^b   Rao, D C ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e IL   (United States)

^f NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

ACE; AGT; Black; case control study; Caucasian; epistasis; gene interactions

Indexed keywords

ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE;

ARTICLE; ATHEROSCLEROSIS; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

AFRICAN CONTINENTAL ANCESTRY GROUP; ANGIOTENSINOGEN; BODY MASS INDEX; CASE-CONTROL STUDIES; CORONARY DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE DELETION; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MASSACHUSETTS; MINNESOTA; MYOCARDIAL INFARCTION; NORTH CAROLINA; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0031056996     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-2797(96)00105-6     Document Type: Article

References (32)

1. 1. Gavras H, Gavras I. Cardioprotective potential of angiotensin converting enzyme inhibitors. J Hyper. 1991;9: 385-392.
2. 2. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. New Engl J Med. 1992;327:669-677.
3. 3. Cambien F, Poirer O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992;359:641-644.
4. 4. Tiret L, Kee F, Poirier O, et al. Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet 1993;341:1991-1992.
5. 5. Nakai K, Itoh C, Miura Y, et al. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation. 1994;90:2199-2202.
6. 6. Ludwig E, Cornell PS, Anderson JL, et al. Myocardial infarction associated with the angiotensin-converting enzyme gene requires development of coronary stenosis. Circulation. 1995;91:2120-2124.
7. 7. Kamitani A, Rakugi H, Higaki J, et al. Enhanced predictability of myocardial infarction in Japanese by combined genotype analysis. Hypertension. 1995;25:950-953.
8. 8. Schunkert H, Hense H-W, Holmer SR, et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med. 1994;330:1634-1638.
9. 9. Kupari M, Perola M, Koskinen P, Virolainen J, Karhunen PJ. Left ventricular size, mass, and function in relation to angiotensinogen-converting enzyme gene polymorphism in humans. Am J Physiol. 1994;36:H1107-H1111.
10. 10. Bonithon-Kopp C, Ducimetiere P, Touboul P-J, et al. Plasma angiotensin-converting enzyme activity and carotid wall thickening. Circulation. 1994;89:952-954.
11. 11. Raynolds MV, Bristow MR, Bush EK, et al. Angiotensin-converting enzyme DD genotype in patients with ischemic or idiopathic dilated cardiomyopathy. Lancet 1993;342:1073-1086.
12. 12. Bonn M, Berge KE, Bakken A, Erikssen J, Berg K. Insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and myocardial infarction. Clin Genet. 1993;44:292-297.
13. 13. Miettinen HE, Korpela K, Hämäläinen L, Kontula K. Polymorphisms of the apolipoprotein and angiotensin converting enzyme genes in young North Karelian patients with coronary heart disease. Hum Genet. 1994;94:189-192.
14. 14. Lindpaintner K, Kreutz R, Stampfer MJ, et al. A prospective case-control study of angiotensin-converting enzyme genotype and the risk for myocardial infarction. Circulation. 1994;90:2538.
15. 15. Tiret L, Rigat B, Visviki S, et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet. 1992;51:197-205.
16. 16. MacGregor GA, Markandu ND, Roulston JE, Jones JC, Morton JJ: Maintenance of blood pressure by the renin-angiotensin system in normal man. Nature. 1981;291:329-331.
17. 17. Dzau V. Cell biology and genetics of angiotensin in cardiovascular disease. J Hyper. 1994;12:S3-S10.
18. 18. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al. Molecular basis of human hypertension: Role of angiotensinogen. Cell. 1992;71:169-180.
19. 19. Hata A, Namikawa C, Sasaki M, et al. Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest. 1994;93:1285-1287.
20. 20. Ward K, Hata A, Jeunemaitre X, et al. Molecular variant of angiotensinogen associated with preeclampsia. Nature Genet. 1993;4:59-61.
21. 21. Katsuya T, Kotke G, Yee TW, et al. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet. 1995;345:1800-1803.
22. 22. Borecki IB, Province MA, Ludwig EH, et al. Associations of candidate loci angiotensinogen and angiotensin-converting enzyme with severe hypertension: The NHLBI Family Heart Study. (In preparation).
23. 23. ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) study: Design and objectives. Am J Epidemiol. 1989;129(4):687-702.
24. 24. Higgins M, Province M, Heiss, G, et al. The NHLBI Family Heart Study: Objectives and design. Am J Epidemiol. (In press).
25. 25. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acid Res. 1992;20:1433.
26. 26. SAS Institute Inc. SAS/STAT® User's Guide, Version 6 V. 1-2. 4th ed. Cary, NC: SAS Institute, Inc.; 1989.
27. 27. Evans AE, Poirier O, Kee F, et al. Polymorphisms of the angiotensin-converting-enzyme gene in subjects who die from coronary heart disease. Quarterly J Med. 1994;87:211-214.
28. 28. Tiret L, Bonnardeaux A, Poirier O, et al. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 1994;344:910-913.
29. 29. Barley J, Blackwood A, Carter ND, et al. Angiotensin converting enzyme insertion/deletion polymorphism: Association with ethnic origin. J Hypert. 1994;12:955-957.
30. 30. Rotimi C, Morrison L, Cooper R, et al. Angiotensinogen gene in human hypertension: Lack of an association of the 235T allele among African Americans. Hypertension. 1995;24:591-594.
31. 31. Bloem LJ, Manatunga AK, Tewksbury DA, Pratt JH. The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest. 1995;95:948-953.
32. 32. Schacter F, Faure-Delanef L, Guenot F, Rouget H, et al. Genetic associations with human longevity at the apo E and ACE loci. Nature Gen. 1994;6:29-33.